72
Participants
Start Date
April 9, 2008
Primary Completion Date
December 16, 2008
Study Completion Date
December 23, 2008
pregabalin
75mg bid titrating to 150mg bid on day 4
pregabalin/PF-00489791
Pregabalin 75mg bid titrating to 150mg bid on day 4; PF-00489791: 4mg od titrating to 10mg od on day 4
Placebo
Placebo
Finger Lakes Clinical Research, Rochester
John P. Murtha Neuroscience and Pain Institute, Johnstown
Memorial Medical Center, Johnstown
Absolute Primary Care, P.C., Cranberry Twp.
The Center for Clinical Research, Winston-Salem
North State Clinical Research, PLLC, Lenoir
Office of Laszlo J Mate, M.D., West Palm Beach
Arthritis Associates of South Florida, Delray Beach
Delray Research Associates, Delray Beach
Parkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton
Bradenton Research Center, Bradenton
North Alabama RadioPharmacy, Huntsville
Tennessee Valley Pain Consultants, Huntsville
River Region Research, LLC, Tallassee
CRC of Jackson, Jackson
Physician's Surgery Center, Jackson
Patient Priority Clinical Sites, LLC, Cincinnati
Legacy Pharma Research, Bismarck
American Medical Research, Inc., Oak Brook
Clinvest, Springfield
Centennial Park Medical Building, North Platte
Neurology Associates of Great Plains, North Platte
Lynn Health Science Institute, Oklahoma City
Mark A. Fisher, MD-Private Practice, Oklahoma City
Medical and Surgical Clinic of Irving, Irving
Pinnacle Pain Medicine, Dallas
Medical Clinic of North Texas, Arlington
The Medical Group Of Texas, Fort Worth
FutureSearch Trials of Neurology, Austin
Futuresearch Trials, Austin
Novara Clinical Research, Mesa
Radiant Research, Chandler
Prime-Care Clinical Research, Mission Viejo
Community Medical Providers, Clovis
Sierra Medical Research (Administrative only site), Fresno
Beacon Clinical Research, Brockton
ICPS Group, Norwood
Neurological Research Center at Hattiesburg Clinic, Hattiesburg
New England Center for Clinical Research, Cranston
Lead Sponsor
Pfizer
INDUSTRY